极光vp n下载官网ios

极光vp n下载官网ios

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

极光vp n下载官网ios

Learn More
Folded page of a newspaper

极光vp n下载官网ios

极光vp n下载官网ios

Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results

极光vp n下载官网ios

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

极光vp n下载官网ios

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

极光vp n下载官网ios

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

极光vp n下载官网ios

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

极光vp n下载官网ios

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

旋风vp加速器pc  老王外网加速  PC外网npv加速器  旋风加速度器网址多少  极光∨pn官网  蚂蚁加速npv官网下载  vp.加速器